Aimmune Therapeutics AR101 peanut allergy

Company News

Aimmune starts POSEIDON trial to treat peanut allergy

Aimmune Therapeutics has commenced the Peanut Oral Immunotherapy Study of Early Intervention for Desensitisation (POSEIDON) trial. POSEIDON is a Phase…